Heart attack patients in Scotland are repeatedly being denied the latest life-saving treatments to save money, a leading cardiologist has warned. Professor Keith Oldroyd, director of research and development at the flagship Golden Jubilee National Hospital in Clydebank, said Scotland lagged years behind the rest of the UK and Europe when it came to introducing new drugs and techniques.
Professor Oldroyd said cardiologists had been waiting for 18 months to start using a drug called ticagrelor, which has been shown to increase the survival chances of heart-attack victims. NHS Greater Glasgow and Clyde has only agreed to its use in a small number of exceptional cases. Professor Oldroyd explained : "There is a single reason for this restriction and that is cost containment..." (our emphasis)
Professor Oldroyd said cardiologists had been waiting for 18 months to start using a drug called ticagrelor, which has been shown to increase the survival chances of heart-attack victims. NHS Greater Glasgow and Clyde has only agreed to its use in a small number of exceptional cases. Professor Oldroyd explained : "There is a single reason for this restriction and that is cost containment..." (our emphasis)
No comments:
Post a Comment